ImClone Closing Branchburg, New Jersey Manufacturing Facility
"This decision was made after careful consideration of a number of internal and external factors related to Erbitux [a cancer drug]," said Janice Chavers, an Eli Lilly spokesperson. "The decision was not driven by Lilly's larger restructuring effort."
ImClone currently has 90 open positions for which employees affected by the layoffs will have priority. The closure plans are effective immediately.
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Hot Jobs: Growing Industrial Sectors
A Site Selector’s Checklist for Locating in the U.S.
Location USA 2019
Where to Invest in the Booming Aerospace Manufacturing Industry
2019 Auto/Aero Site Guide
Hiring Challenges Continue Throughout the U.S.
Tips for Navigating Incentives in Site Selection Process